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But I have promises to keep, 
And miles to go before I sleep, 
And miles to go before I sleep.  
Robert Frost. 
To  
My appa and amma 
  
ABSTRACT 
Genetic factors play a substantial role in susceptibility to common diseases such as type 
2 diabetes (T2DM) and obesity-related disorders. The current investigation was 
undertaken to examine the association of genetic variants that indirectly affect diabetes-
related traits through their effects on birth weight and adiposity in South Asian Indians. 
Additionally, the thesis was extended to examine the plausibility of differences in body 
composition in Asian Indians, compared to the West, as a contributing factor to 
premature cardio-metabolic risk in Indians.   
 
The first study investigated the association of two birth-weight lowering genetic 
variants in the ADCY5 and near CCNL1 locus with birth weight and adult glycemic 
traits. Although the significant associations between both genetic variants and birth 
weight as observed in Western cohorts were not seen, the ADCY5 variant displayed an 
association with increased glucose and decreased fasting insulin response, which 
supports the fetal-insulin hypothesis proposing a common genetic factor linking birth 
weight and adult T2DM traits. Recent GWAS have shown that associations of certain 
variants with birth weight is secondary to their effects on adiposity, and the strong link 
between obesity and T2DM stimulated further examination of the effect of genetic 
variants on obesity and diabetes-related traits. In Paper II, it was confirmed that the 
common FTO variant exerts an effect on obesity traits in adult Indians similar to that in 
Caucasians. A subsequent investigation (Paper III) of the effects of FTO and MC4R in 
adolescents (mean ± SD age, 17.1 ±1.9 years) demonstrated an association with waist-
hip ratio, providing evidence that the preferential accumulation of central fat in Indians 
is regulated by FTO in younger age groups. This could be a constitutional Asian Indian 
effect, and underpins the importance of ethnic-specific differences in fat distribution. 
These FTO associations with obesity and T2DM traits in adults were further 
strengthened by a meta-analysis of ~23,000 Asian Indians (Paper IV), in which a 
consistent obesity-related effect was observed, in addition to an effect on T2DM which 
seemed to be partially mediated through body mass index (BMI). The strong 
association of FTO with waist circumference and subcutaneous adipose tissue (SAT) 
proxies led to an investigation of the differences in abdominal adiposity depots in 
Indians compared to Caucasians, using dual energy X-ray absorptiometry (DXA) as 
described in Paper V.  Compared with a BMI-, gender- and age-matched Western 
cohort, Asian Indians exhibited relatively less visceral fat accumulation and more 
subcutaneous fat, reinforcing that ethnic differences in fat distribution need to be 
appreciated when analyzing the connection between obesity and T2DM. 
 
In conclusion, the effect of ADCY5 on glucose regulation confirms that impaired 
glucose homeostasis in adulthood is related to birth weight mediated through 
mechanisms that involve fetal-insulin signaling. Regarding genetic effects on adiposity, 
the effect estimate of the FTO locus on obesity and diabetes-related traits in Asian 
Indians is similar to that in Western ethnicities. The relative absence of differences in 
visceral adiposity, and a predominance of subcutaneous fat accumulation along with 
lower muscle mass and higher overall body fat in Asian Indians, provides novel 
insights to investigate the role of specific adipose depots and skeletal muscle in relation 
to heightened cardio-metabolic risk in this population.   
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1 BACKGROUND  
The ongoing world-wide obesity and diabetes epidemic, especially in developing 
countries such as India, has spurred researchers to investigate potential factors that 
contribute to the increase disease risk in different populations. Variability in disease 
susceptibility is attributed to differences in the genetic architecture, environmental 
interactions and body composition across various ethnic groups. Asian Indians are 
intrinsically different from the Western population in certain distinct phenotypic 
characteristics such as lower birth weight (LBW), hyperinsulinemia since birth and 
increased adiposity at any given body mass index (BMI) (1-3). It is unclear as to which 
factor actually confers increased risk for cardio-metabolic disease in Asian Indians as 
all three factors appear to be mutually exclusive and complement one another. The 
current thesis was therefore undertaken to investigate one possible mechanism that 
relates specifically to genetic variants that modulate disease risk at three levels: birth 
weight, adiposity and early alterations in glucose-insulin homeostasis. Such genetic 
variants that have an effect on one or more of these traits will influence the other(s), 
thereby acting as a common connecting link between all traits. To complement the 
genetic findings, the thesis additionally examined differences in body composition, 
specifically relating to abdominal adiposity, in migrant Asian Indians, compared to 
Caucasians. 
 
1.1 GENETICS 
1.1.1 The Human Genome 
The human genome is packaged into 23 pairs of chromosomes within the nucleus of 
cells, with a minor proportion also found in the mitochondria. The genome comprises 
of approximately 2.9 billion nucleotides, and includes both the coding genes and the 
non-coding genome (4). The coding genes contribute to approximately 1.5% of the 
entire genome, and are made up of nucleotide codons that undergo transcription and 
translation to form peptides or proteins (5). The non-coding genome contains sequences 
of diverse function and includes noncoding RNA (transfer RNA and ribosomal RNA), 
pseudogenes, introns, untranslated regions of mRNA, regulatory DNA sequences, 
microRNAs, repetitive DNA sequences and sequences related to mobile genetic 
elements (5-7).  
 
1.1.2 Genetic variation 
Both the coding genes and the non-coding genome determine the phenotypic 
characteristic of an individual (8). However, the majority (above 90%) of the trait-
associated variants identified by genetic studies resides within the non-coding genomic 
sequences (9). Variation within the genome can be identified as single nucleotide 
polymorphisms (SNPs), insertions, deletions, copy number variations (CNV) and 
chromosomal rearrangements (10). Indeed, not all genetic variation results in changes 
in either protein structure or gene regulation, and may not necessarily contribute to the 
differences in phenotypic characteristics (8, 11). Genomic similarity within humans has 
been estimated to be about 99.9%, which means that only about 0.1% of the genome 
sequence is different between individuals (9, 12). However, this 0.1% of the total 
sequence harbors more than 2 million variants, and these variations confer genetic risk 
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to common diseases (13). Identification of these genetic variants therefore is important, 
as they provide mechanistic insights into pathways of disease development.  
  
1.1.3 Monogenic disease 
Monogenic diseases occur due to a single mutation in one or both alleles and exhibit a 
familial clustering with a clear inheritance pattern (14). Maturity onset diabetes of the 
young (MODY) is a classical monogenic form of diabetes that results from mutations 
in genes that are expressed in the pancreatic β-cells, or genes that regulate the the 
insulin secretion pathway (15, 16). Other forms of monogenic diabetes include neonatal 
and mitochondrial diabetes (17). Rare functional variants in genes involved in the 
leptin-melanocortin pathway such as leptin receptor (LEPR), pro-opiomelanocortin 
(POMC), pro-hormone convertase subtilisin/kexin type 1 (PCSK1) and the 
melanocortin receptor-4 receptor (MC4R) have been shown to cause severe early-onset 
monogenic obesity (18).  
 
1.1.4 Genetics of complex disease (Polygenic disease)  
Polygenic or complex diseases are diseases that result from the interaction of several 
genes, each exerting a minor contribution to overall disease risk, with or without the 
involvement of non-genetic factors (19). Complex disease genetics are studied either by 
an association approach, in which the frequency of risk alleles or genotypes are 
compared between cases and controls, or by a genome wide approach, in which most of 
the genome is surveyed for associations with a phenotypic trait of interest (20, 21). 
Genetic variants that underlie complex traits usually have subtle effects on disease risk 
and therefore require large sample sizes to determine the true magnitude of the effect 
on the trait (21, 22). The usual conclusion derived from such studies is that a detected 
polymorphism either affects the disease/trait directly, or is a marker of a nearby causal 
variant that affects disease risk (23).  
 
1.2 GENETIC EPIDEMIOLOGY 
Genetic epidemiology facilitates the design and implementation of studies aimed at 
identifying and characterizing genes that influence phenotypic traits (24). This involves 
characterization of the effect of genetic variants at a population level by exploring the 
correlations with trait using two main strategies: i) candidate-gene approach; ii) 
genome-wide association approach (25).  
 
1.2.1 Candidate gene studies 
The candidate gene approach is a simple, straight forward,  hypothesis-driven method 
employed to test the association of a particular genetic variant (allele) with a 
disease/trait (26). The basis of selection of candidate genes depend on their role in the 
biological pathways / mechanisms related to phenotype of interest or on their location 
in previously determined region of linkage. An increased frequency of the risk-
determining allele in a population infers that either a causal relationship exists between 
the genetic variant and the phenotypic trait (disease), or that the variant is in linkage 
disequilibrium (LD) with the disease gene near the locus in question (27). Candidate 
gene studies are potentially powerful and represent the most commonly employed 
method to identify genetic variants that influence disease susceptibility. However, they 
are plagued by certain limitations such as small sample size, limited number of variants 
assayed, and the generation of false-positive associations, all contributing to the  
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inconsistencies in reproducibility between populations (20, 27-29). In the recent past, 
issues concerning the power of genetic association studies has been tackled by either 
using larger sample sizes, or by combined meta-analysis of well-designed smaller 
studies to understand the true magnitude of genetic effect (30, 31). 
 
1.2.2 Genome wide association studies (GWAS) 
Genome wide association studies (GWAS) represent a powerful new tool to investigate 
the genetic architecture of complex diseases. This is a hypothesis-free approach where 
a dense set of SNP markers (~0.1-5 million) spanning the entire genome is scanned in 
thousands of individuals, using high-throughput genotyping platforms (32). The design 
of GWAS is based on the ‘common disease, common variant hypothesis’, which 
considers that common diseases are attributable to allelic variants present in more than 
1-5% of the population (10). The sequencing of the human genome (33), and the 
availability of databases of SNPs such as dbSNP (http://www.ncbi.nlm.nih.gov/SNP/), 
and the International HapMap (http://hapmap.ncbi.nlm.nih.gov/), which provide 
information on >2.5 million SNPs, have allowed early GWAS to study common 
variants (minor allele frequency: MAF >1%) that associate with disease. More recently, 
the 1000 genome project (http://www.1000genomes.org/), which includes more than 37 
million variants including both rare and low frequency variants (MAF <0.5% and 0.5-
5%, respectively), is expected to increase the success of GWAS in identifying 
associations of such rare variants in complex disease etiology. The GWAS approach 
includes a discovery and a replication stage. They resolve genome wide associations at 
stringent significance levels (P ≤ 5 x 10-8), after applying an appropriate correction 
factor for multiple testing (34). This cut-off is based on the estimated number of 
significant tests in the genome if all common SNPs in the HapMap were tested either 
by direct genotyping or by imputation (21). The GWAS approach has no a priori 
assumptions about genes and therefore has been successful in identifying several novel 
variants that associate with complex disease, but mostly in Caucasians. Large-scale 
obesity-related GWAS in indigenous Asian Indians are sparse, whilst fewer studies 
have included migrant Asian Indian populations (35-37). In such migrant populations, 
the presence of confounding factors such as population admixture and environmental 
effects have not been dealt with adequately. Therefore, a need to conduct de novo 
studies within Asian Indians is important to confirm the genetic associations that have 
emerged as strong signals in other ethnicities and also identify novel variants specific to 
this population. This would provide insights into understanding the genetic contribution 
to complex diseases that are specific to Asian Indians.  
 
1.3 OBESITY / ADIPOSITY 
Obesity results from excessive accumulation of body fat within the subcutaneous and 
visceral compartments of the human body. With increasing adiposity, enlarged 
dysfunctional adipocytes within the subcutaneous region lose their ability to 
appropriately store excessive fat, resulting in spill-over of fat and subsequent 
accumulation in ectopic compartments such as liver and skeletal muscle (38). The 
excessive fat at these ectopic sites disrupts normal metabolic signaling, leading to 
obesity-related complications (39).  
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1.3.1 Obesity epidemiology 
Obesity is a growing world-wide epidemic, and estimates of its prevalence are rapidly 
increasing both in developing and developed countries. The International Obesity Task 
Force (IOTF) and the World Health Organization (WHO) report that over 1.1 billion 
adults worldwide are overweight, of which 312 million are obese (40). The obesity 
prevalence in adults increasing obesity estimates in childhood, with worldwide 
prevalence estimated to be 6.7% in 2010 (Global Infobase WHO, May10, 2010). Over 
the past 20 years, obesity rates have tripled in the developing countries, reflecting 
substantial changes in behavioral patterns which include adoption of characteristics of a 
Western lifestyle (decreased physical activity and overconsumption of inexpensive, 
high calorie foods and drinks) (41). The exact prevalence of obesity among Asian 
Indians is unknown, but the increase in obesity-related complications in this population 
is attributed to a higher proportion of body fat, specifically in the abdominal 
compartment (42, 43).  
 
1.3.2 Obesity and related complications 
Obesity is associated with a number of metabolic consequences including 
hyperinsulinemia, insulin resistance (IR), type 2 diabetes (T2DM), dyslipidemia, 
hypertension, cardiovascular disease (CVD), and predisposes to higher risk for 
premature mortality (44-46) including deaths related to cancer (47). Obesity often leads 
to dysregulation of endocrine, neural and inflammatory pathways that contribute to the 
development of IR. Low-grade chronic inflammation leading to abnormal 
inflammatory profile is often observed in the adipose tissue of obese individuals, and 
are usually associated with  adipocyte hypertrophy (increased size) caused by storage of 
excessive lipids (48) and/or adipocyte hyperplasia (increase in number) (49, 50). This 
in turn affects pathways such as insulin signaling in target peripheral tissues, leading to 
a cascade of events that perpetuate metabolic consequences (51, 52). 
 
1.3.3 Subcutaneous and Visceral adiposity 
The abdominal fat compartment includes both subcutaneous and visceral adipose 
tissues (SAT and VAT, respectively). The SAT compartment is further subdivided 
anatomically into the superficial subcutaneous fat (sSAT) and deep subcutaneous fat 
(dSAT), separated by a thin facial plane called the scarpia fascia (53). Both SAT and 
VAT are heterogeneous and differ in their morphology and metabolic characteristics 
(54). Numerous studies have convincingly reported the association of VAT with 
metabolic abnormalities such as glucose intolerance, hyperinsulinemia and 
dyslipidemia in individuals matched for total body fat (55, 56) and SAT (57, 58). 
However, recently it was shown that SAT correlates with metabolic abnormalities to 
the same magnitude as VAT (59-61). Although, there is sufficient evidence to support 
the concept that adiposity per se is related to metabolic complications, the relative 
importance of the different fat depots remains highly debated. Anthropometric 
measurements such as waist circumference (WC) measure total abdominal adiposity 
including both SAT and VAT, while skin fold measurements reflect SAT at measured 
sites.  Quantification of abdominal adiposity volumes involving either a single slice 
(L1-L2 or L3-L4) or sequential abdominal imaging of the abdomen using computed 
tomography (CT) (62) or magnetic resonance imaging (MRI) (63) have provided a 
better understanding of relative contributions of adiposity depots to metabolic 
characteristics. Recently, ultrasound and dual energy X-ray absorptiometry (DXA) 
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scans (64) have gained popularity for quantification of visceral depots, owing to their 
ease of use and minimal radiation exposure.  
 
1.3.4 Assessment of obesity phenotypes 
Numerous epidemiological studies provide strong evidence for an association between 
higher BMI and increasing morbidity and mortality, albeit differences in the strength of 
the associations between various ethnic groups. This has led to ethnic-specific BMI cut-
offs for defining obesity (65, 66). Although BMI is the most frequently-used indicator 
of fatness both in clinical and population studies, its use in defining obesity lacks 
precision due to its inability to differentiate between fat and muscle mass (67, 68). 
Also, BMI does not account for heterogeneity of regional body fat deposition. WC, an 
indicator of abdominal fatness, has also shown a strong association with cardiovascular 
risk (69, 70). Measurement of WC is particularly important in certain ethnic groups 
such as Asian Indians, who have a greater predilection to central obesity. The ratio of 
abdominal waist over hip circumference (WHR) is another index of body fat 
distribution, and has shown higher predictive ability for cardiovascular and T2DM risk 
(69). The superiority of one measurement over the other is debated. Nevertheless, BMI 
measures overall fatness, while other measurements are more specific and reflect 
regional adiposity.  
 
Table 1: Cardio-metabolic risk cut-offs, based on anthropometric measurements in 
Indians and Caucasians 
 
Anthropometry            Indians          Caucasians 
Body Mass Index (kg/m2)  
Normal                                    < 22.9 kg/m2                   ≤ 24.9 kg/m2 
Overweight                           23-24.9 kg/m2                 25-29.9 kg/m2 
Obese                                         ≥ 25 kg/m2                             ≥ 30 kg/m2 
Waist circumference (cm) 
Men             90 cm             102 cm 
Women             80 cm               88 cm 
Waist-Hip ratio 
Men             0.88                  0.90 
Women             0.80                  0.85 
 
Skin fold thickness (SFT) measured at various sites reflects regional subcutaneous 
adipose tissue (SAT) (71), and provides information on changes in the distribution of 
body fat (central and peripheral fat). SFT is also used in the estimation of body fat 
percentage (BF%) by employing standard prediction equations (72, 73). All 
anthropometric markers are indirect measures of adiposity and do not quantify fat mass 
(SAT+VAT). Approaches which quantify adipose tissue volume/masses empirically, 
such as CT, MRI or DXA scans, are gaining more popularity in obesity research.  
 
1.3.5 Genetics of obesity 
Family and twin studies have shown that 40-70% of the inter-individual variation in 
common obesity is attributable to heritable factors (74). This clearly demonstrates that 
body weight has a large underlying genetic component which determines an 
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individual’s susceptibility to weight gain. Studies have also reported the heritability 
estimates of obesity-related traits to be as follows: BMI (50-80%) (74, 75), WC (46-
90%) (76, 77), WHR (6-61%) (77, 78), which further strengthens the understanding 
that numerous genes could impact the expression of obesity-related phenotypes. From a 
genetic stand point, obesity is classified as monogenic, syndromic and polygenic 
obesity. Variants associated with monogenic obesity, such as MC4R and brain-derived 
neurotropic factor (BDNF), have also shown an association with common obesity (79, 
80) The candidate gene approach to identify variants associated with obesity has largely 
been unsuccessful, whilst GWAS have successfully identified several novel variants 
that associate with obesity and related traits. Insulin-induced gene 2 (INSIG2) was the 
first locus to be reported in obesity-focused GWAS (81), but replication efforts were 
inconsistent. Variants in the fat mass and obesity-associated (FTO) gene, and variants 
near the MC4R locus, have demonstrated the most robust association with obesity traits, 
along with consistent replication in several ethnic groups (79, 82). GWAS that followed 
identified several novel loci that are associated with obesity-related quantitative traits.  
Employing data from 61 genome wide scans, the Human Obesity Gene Map has 
reported the identification of 127 candidate genes and 253 quantitative trait loci linked 
and/or associated with obesity-related phenotypes (83), many of which have only a 
poorly understood function. The obesity variants identified so far, are usually genes that 
regulate one or more of the following processes: energy homeostasis and 
thermogenesis, appetite regulation, adipogenesis, and leptin or insulin signal 
transduction (84), suggesting that that a majority of such genes are associated with 
hypothalamic function. However, the combined effect of the variants identified by 
GWAS accounts only for ~1-2% of genetic variation in BMI due to lower effect sizes 
(85). The remainder of the unexplained variation, or ‘missing heritability’, is thought to 
be explained by genetic variation other than the common DNA variants, such as gene-
gene interactions, gene-environment interactions (86), copy number variants (CNV) 
(87), low frequency genetic variants with larger effect sizes and epigenetic factors (88). 
The current challenge remains to identify these new variants and understand the 
underlying biological mechanisms of these loci in conferring obesity risk. Combined 
approaches using molecular genetics, sophisticated techniques in quantifying adiposity 
and functional studies would provide a more vivid understanding of common obesity.   
 
1.4 TYPE 2 DIABETES 
T2DM is a heterogeneous disorder of carbohydrate and lipid metabolism and 
progresses through stages of normal glycaemia to impaired fasting glucose (IFG), 
impaired glucose tolerance (IGT) and subsequent T2DM. It is caused by both genetic 
and environmental factors, of which obesity is overwhelmingly the most important 
intermediate trait. The life time risk of developing T2DM if one parent has T2DM is 
about 40%, and this increases to 70% if both parents are affected (89, 90). The 
concordance rate of T2DM in monozygotic and dizygotic twins is reported to be 70% 
and 30%, respectively (91, 92).  
 
1.4.1 Epidemiology and pathogenesis 
T2DM is now emerging as a pandemic, with an increase in world-wide prevalence 
from 194 million in 2003 to an estimated 439 million cases by the year 2030 (93). The 
increase is likely to be most evident in developing countries due to population growth, 
aging, rapid urbanization, an unhealthy/hyper-caloric diet and a sedentary life style 
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leading to obesity (94). Estimates based on population growth and rapid urbanization 
show that India and China will be world leaders in the number of patients with T2DM 
by 2030, corresponding to 79.4 million and 42.3 million individuals, respectively (95). 
Obesity leads to insulin resistance (IR) and the inability of the peripheral tissues 
(muscle, liver and adipose tissue) to respond to physiological concentrations of insulin. 
The pancreatic β-cell is unable to compensate for the increasing demands for insulin 
secretion, and a relative deficiency in glucose-mediated insulin release is the main 
mechanism involved in the pathogenesis of T2DM (96).  
 
1.4.2 Assessment of diabetes related traits 
Markers of reduced insulin sensitivity (IS) and insulin secretion are often used as proxy 
measurements in population-based studies. Studies based on twin and family studies 
have reported heritability estimates for IS and insulin secretion to range from 50-78% 
and 47-59%, respectively (96, 97). Direct measure of insulin sensitivity can be carried 
out either by assessment of glucose disposal during a hyperinsulinemic-euglycemic 
clamp, or by an insulin suppression test. Insulin secretion may be measured either 
during the hyperglycemic clamp or by frequent sampling during an intravenous glucose 
tolerance test (98). Since these tests are laborious, time consuming and require hospital 
admission of patients, they are not suitable for epidemiological studies. Therefore, 
indirect measures of IS/IR and insulin secretion derived from fasting insulin and 
glucose concentrations, or from repeated sampling following an oral glucose tolerance 
test (OGTT), are often used in field studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow chart showing methods used in the assessment of diabetes-related traits 
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The commonly used surrogate measures derived from OGTT that were used in the 
current investigation are discussed subsequently. 
 
1.4.3 Genetics of type 2 diabetes 
Genetic variants associated with T2DM usually affect pathways that involve β-cell 
function, adiposity or insulin resistance per se (99).  By linkage analysis two genes, 
namely calpain 10 (CAPN10) (100) and transcription factor 7-like 2 (TCF7L2) (98) 
were identified as T2DM associated genes (101). Associations with T2DM of 
functional or positional candidate genes have also been extensively reported, but so far 
only 6 genes have shown consistent associations; these include the Pro12Ala variant in 
the peroxisome proliferator-activated receptor gamma (PPARG) gene (102), insulin 
receptor substrate 1 (IRS1) (103), Glu32Lys variant in the potassium inwardly-
rectifying channel, subfamily J, member 11 (KCNJ11) (104), Wolfram syndrome 1 
(WFS1) (105), and HNF1 homeobox A (HNF1A) and B (HNF1B) (103). The first 
GWAS on T2DM identified hematopoietically-expressed homeobox (HHEX) and 
solute carrier family (Zinc transporter) member (SLC30A8) as being associated with 
T2DM (106). Subsequent GWAS reported robust associations for cyclin-dependent 
kinase inhibitor 2A and 2B (CDKN2A/CDKN2B), insulin-like growth factor 2 binding 
protein 2 (IGFBP2), CDK5 regulatory subunit associated protein 1-like 1 (CDKALI) 
and TCF7L2 with T2DM (103, 104, 107). Several GWAS and large scale meta-
analyses thereof confirmed these signals and additionally identified new loci associated 
with diabetes and related glucose-insulin traits both in European (106, 108, 109) and 
non-European ethnicity (110, 111). Currently over 60 loci have been associated with 
T2DM and related traits (112). However, the combined effect of these variants explains 
only 5-10% of disease risk, since most of the identified variants demonstrate very 
modest effect sizes ranging from 1.05 to 1.15; the only exception being TCF7L2, which 
has an odds ratio of 1.37 (113). Whether variants included in the ‘missing heritability’ 
concept could explain the remaining risk is highly debated, as for any other complex 
disease. Nevertheless, these variants have provided great insights into the 
understanding of the pathogenesis that underlies T2DM. 
 
1.4.4 Diabetes and obesity - connecting link 
The link between obesity and T2DM involves two main mechanisms: IR and β-cell 
failure. Obesity that results from an imbalance between energy intake and expenditure, 
leads to alterations in several pathways involving inflammatory signaling (114), 
endoplasmic reticulum stress (115), increased production of reactive oxygen species, 
mitochondrial dysfunction (116) and increased accumulation of triglycerides and free 
fatty acids (117). These mechanisms may not be mutually exclusive, and are usually 
inter-linked, with one leading to another. The net result of such alteration is increased 
free fatty acids in circulation leading to fatty acid overload in the liver and skeletal 
muscle. This results in decreased responsiveness of the peripheral tissues to insulin 
leading to IR (52). Genetic factors may additionally predispose an individual to reduced 
β-cell capacity which could otherwise compensate for the increasing demands on 
insulin secretion imposed by the IR. Such progressive β-cell dysfunction may further 
worsen the situation by causing prolonged increases in the concentrations of glucose, 
free fatty acids and other substances that lead to cellular injury (117). This in turn may 
trigger an inflammatory cascade, with the recruitment of macrophages and other 
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immune cells further exacerbating the inflammatory milieu, thus establishing a vicious 
cycle (118). Genes implicated in obesity susceptibility such as FTO, MC4R, 
transmembrane protein 18 (TMEM18), glucosamine-6-phosphate deaminase 2 
(GNPDA2), SH2B adaptor protein 1 (SH2B1) and neuronal growth regulator (NEGRI1) 
have also shown associations with T2DM, thus providing a common genetic link 
between both disease states (82, 119). Typically, the association between these gene 
variants and T2DM disappears if appropriate adjustment for obesity is made between 
cases and controls. 
 
 
1.5 DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE 
(DOHaD)  
The DOHaD theory proposes that chronic disease susceptibility in adulthood is 
influenced not only by the inherent genetic and post-natal lifestyle, but also by the in 
utero environment that the fetus is exposed to (120). The in utero environment is 
governed by maternal factors such as maternal nutrition, placental function, substance 
abuse, maternal stress and illness during pregnancy. These factors regulate fetal growth 
through mechanisms that cause permanent structural changes, affect epigenetic 
programming of gene expression and accelerate cellular ageing (121). As a 
consequence of these effects, the embryo/fetus, being highly sensitive to the 
perturbations of the maternal environment, undergoes alterations during critical periods 
of development which have a long-term health impact during adulthood. The 
developmental origins theory can be linked back to the ‘thrifty phenotype’ hypothesis 
proposed by Barker and colleagues, who demonstrated a relationship between birth 
weight (as a proxy measure of adverse fetal environment) and adult disease. These 
authors concluded that sub-optimal fetal nutrition during critical time points of 
intrauterine development may cause permanent alterations in fetal structure, function 
and metabolism, due to skewed developmental programming (122, 123). These theories 
are not mutually exclusive, but complement one another. Most epidemiological studies 
have relied on ‘birth weight’ as a proxy indicator of in utero nutrition. However, the 
relative contributions of birth weight and subsequent body size to adult disease vary 
between specific disease markers and between populations, with some ethnic groups 
demonstrating weak or no significant relationship and other populations showing a 
stronger relationship (124-127). 
 
1.5.1 Fetal-insulin hypothesis 
The fetal insulin hypothesis (FIH) proposed by Hattersley and Tooke (2002) states that 
genetic variants that associate with glucose-insulin homeostasis may cause impaired 
insulin-mediated growth prenatally, eventually resulting in low birth weight and 
adverse metabolic outcomes in adulthood (128). Genetic variants in the glucokinase 
(GCK) gene which are associated with monogenic diabetes were the first to be shown 
to influence birth weight via maternal genotype (129). The studies that followed 
provided evidence for more common variants that associate with T2DM to influence 
birth weight. For example, polymorphisms in the insulin-like growth factor–1 (IGF-1) 
gene promoter (130) and variants in the  CDKAL1 and HHEX-IDE loci (131, 132) were 
shown to influence birth weight via the fetal genotype.  This birth weight lowering 
effect was modulated through altered pancreatic β-cell function and reduced insulin 
secretion, supporting the fetal-insulin hypothesis. Such evidence has stimulated further 
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research to investigate common genetic determinant which could explain multiple 
phenotypes such as low birth weight and adult T2DM. This would be particularly 
important in vulnerable populations such as Asian Indians, who are born with lower 
birth weight and also have a higher risk for T2DM and CVD. Such studies could 
provide a possible explanation for the ongoing obesity and T2DM epidemic in India. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Proposed causal pathway that explain the association between low birth 
weight and adult metabolic phenotype. (DoHAD: Developmental origins of health and 
disease) 
 
1.5.2 Genetics of low birth weight 
Birth weight heritability estimates vary between 10-40% (133) and are determined by 
fetal and maternal genes as well as by the intra-uterine environment. To date, two 
genetic variants (ADCY5 and CCNL1) identified by GWAS have shown robust 
associations with birth weight via the fetal genotype (134). Other birth weight -
modulating variants include, firstly, CDKAL1 and HHEX-IDE, which appear to operate 
via the fetal genotype, in support of the fetal insulin hypothesis (131), and secondly 
GCK and TCF7L2, which appear to act via the maternal genotype (135). Genetic 
variants that influence birth weight through maternal genotype probably mediate fetal 
growth by a primary effect on maternal glucose levels, increasing fetal insulin secretion 
and subsequently increased fetal growth.  Besides evidence of association between birth 
weight and T2DM (ADCY5 and CDKAL1), there is accumulating evidence of such 
associations with other adult phenotypic traits such blood pressure (ADRB1) and height 
(HMGA2 and LCORL) (136). However, these variants explain only 0.76% of the 
variance in birth weight amongst Europeans, and 0.32-1.52% of the variation in 
populations of Middle Eastern, Southeastern Asian and African origin, leaving ample 
room for non-genetic explanations.   
 
1.5.3 Non-genetic determinants of birth weight  
Studies of non-genetic factors that influence birth weight primarily focus on two 
important events: maternal nutrition during pregnancy and in utero epigenetic fetal 
Low birth weight 
      T2DM genes  in utero fetal growth  
Increased insulin resistance  
                  and/or  
  reduced insulin secretion   
Adult metabolic phenotype   
Fetal insulin hypothesis DoHAD hypothesis 
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programming. Recent reviews on animal models have summarized extensively the role 
of maternal nutrition, maternal hypoxia and/or placental insufficiency in fetal growth 
and development (137, 138). Yajnik et al. showed that higher folate intake in vitamin 
B12-deficient mothers increases T2DM risk in off-spring, secondary to increased 
lipogenesis, increased accumulation of odd-chain fatty acids and greater adiposity 
(139). The role of epigenetic regulation of differential gene expression (140), 
particularly in relation to T2DM genes such as PPARα (141) and HNF4α (142), 
provides a newer understanding of the role of epigenetic mechanisms involved in  
modulating birth weight and subsequent disease. Studies in humans have also shown 
that methylation of the imprinted IGF2 gene, and of genes implicated in early growth 
and metabolism in individuals exposed to the Dutch famine in early life, as possible 
explanations of adult chronic disease susceptibility (143, 144). Therefore, non-genetic 
determinants of birth weight appear to play a role which is as equally important role as 
that of genetic factors which link fetal origins and adult disease.  
 
1.6 ETHNICITY AND IMPACT ON DISEASE  
Ethnic differences in non-communicable disease susceptibility are attributed to 
differences in body composition, genetic background and environmental influences, all 
of which determine metabolic capacity (145, 146). The unique phenotypic 
characteristics of Asian Indians and the relationship to chronic diseases provide 
valuable evidence that ethnic-specific differences in body composition have important 
role in chronic disease risk (147-150).  
 
1.6.2 Ethnic variation in genotypes and differential disease risk 
The phenotypic expression of a certain trait/disease differs among various ethnic 
groups, but the reasons for this are unclear. Differences in the DNA sequence variation, 
gene expression (151), allele frequencies (152, 153), haplotype structure (154) and 
genetic effect per se across populations (155) provide clues that genetic determinants 
may not impart the same population-attributable risk across different ethnic groups 
(110, 156). For example, results from the Indian Genome Variation consortium show 
that a high level of genetic divergence is observed even within Indian subgroups; this 
divergence clusters on the basis of ancestral descent and language and is quite distinct 
from HapMap populations (157, 158). Such genetic differences may partially explain 
the variation in disease susceptibility among Indians and other ethnic groups. These 
observations also point that gene-disease associations cannot be generalized and need 
validation across populations of different ethnicity.  
 
1.6.3 Birth weight and adult disease in Asian Indians 
A series of studies conducted by Yajnik et al. have provided robust epidemiological 
evidence relating to differences in birth weight, body composition and adult disease 
risk in Indians compared to Caucasians. Comparison of measurements of new born 
term Indian and UK-born British babies showed that Indian babies had lower birth 
weight (2.7 vs. 3.5 kg), and were shorter (47.3 vs. 50.2 cm) and thinner (Ponderal index 
24.1 vs. 27.3 kg/cm2). However, subscapular SFT, which reflects SAT, was comparable 
(4.2 vs. 4.8 mm). The ‘thin-fat’ phenotype at birth is attributed to lower lean and 
skeletal muscle mass and to relatively higher adiposity (3, 159, 160). Comparison of 
pre-pregnancy characteristics of Indian and British mothers provides evidence that 
Indian mothers are smaller, thinner and consumed much less energy, protein and 
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micronutrient-rich food (161). Results from the Pune Maternal Nutrition study showed 
that birth weight in Indians was independent of socio-economic status and nutritional 
intake during pregnancy, but was predicted by maternal pre-pregnancy weight (160). 
Put together, this cumulative evidence implies that differences in weight and body 
composition at birth, and maternal nutritional status during pregnancy, are important 
determinants of increased disease susceptibility in adulthood, supporting the fetal 
origins theory. Investigation of the genetic determinants that influence fetal growth 
through maternal genotype will provide additional clues to the genetic modulation of 
birth weight and adult disease risk. 
  
1.6.4 Body composition differences in Indians and Caucasians 
Body composition includes both the lean (fat-free) and fat masses (162). As explained 
previously, the distinct body characteristics of Asian Indians is proposed to relate to 
increased cardio-metabolic risk (67, 163, 164). The metabolic effects attributable to 
central adiposity in this population is largely reported to be due to visceral fat (165, 
166), while recent investigations have demonstrated an excessive SAT contribution to 
central adiposity (147, 167, 168). Interestingly, glucose disposal has been shown to 
inversely correlate with fat mass in all compartments of abdominal adipose tissue, 
suggesting that any given change in abdominal fat correlates with reduced insulin 
sensitivity in Indians (149). The physiological explanation of ethnicity-related 
differences in body composition, particularly in adipose tissue, is linked to inherent 
genetic and epigenetic programming in fat cells to store excess lipids (169).Despite a 
lower lean mass, it is also shown that South Asians have 30% higher intra-myocellular 
triglycerides compared to BMI-matched Caucasians, suggesting the presence of 
dysfunctional skeletal muscle lipid metabolism (170). Both the role of lower skeletal 
mass in Indians, and its relationship with metabolic risk, needs further investigation.  
 
1.6.3 Genetics of obesity in Asian Indians  
The field of obesity genetics in Asian Indians still remains largely unexplored, except 
for a few independent replications of FTO and MC4R variants. The largest GWAS on 
migrant Indians identified a robust association of variants close to the melanocortin-4 
receptor (MC4R) gene with waist circumference and IR (35). Several independent 
studies that followed (171, 172), and a recent meta-analysis, have further confirmed 
this association (173).  
 
Replications of FTO in association with obesity traits have been inconsistent in Indians 
(174-178). A recent GWAS that included migrant Indians in the UK showed an 
association of  FTO with BMI, and additionally identified a novel variant in the IRS1 
locus to be associated with obesity-related traits in Indians (37). A meta-analysis by Li 
et al. which included ~97,000 Asians further confirmed that the FTO-obesity effect in 
Asians is the same as that in Caucasians (179). This study, however, combined both 
indigenous and migrant Indian populations, and a stratified analysis was not performed. 
Besides these well-validated GWAS signals, few independent studies have reported 
new variants that associate with obesity traits in Indians, using candidate gene 
approach; however, these reports were not consistently replicable, and  none of the 
variants detected so far by these studies have shown signals in large scale GWAS of 
populations from European or Asian countries. Previous studies on obesity genetics in 
Indians, and results included in this thesis compels some emphasis regarding 
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investigation of obesity phenotype in Indians: i)  it may not be justifiable to combine 
different ethnicities, even within Asian subgroups, owing to differences in body 
composition ii) BMI is a composite index of both fat and lean mass and does not reflect 
adiposity, particularly in Indians, who are centrally obese iii) genetic associations with 
specific measurements of regional adiposity need further investigation iv) identification 
of genetic variants that associate with different fat depots, measured using sophisticated 
techniques, may further provide insights into the role of genetics in the regulation of 
body weight and fat distribution in Indians.  
 
1.6.4 Genetics of diabetes in Indians 
Viswanathan et al. showed a strong familial aggregation, amongst most Asian Indians 
having at least one first-degree relative with T2DM (180). The genetic susceptibility to 
T2DM has been well studied both by candidate gene and GWAS approach in both 
indigenous and migrant Indian populations, and common susceptibility variants for 
T2DM appear to be shared among Indians and other ethnic groups. The protective 
effect of PPARG2/ProA12Ala on IR and T2DM risk was not consistent (181), although 
in certain sub-populations from North India, a robust association with T2DM was 
confirmed (176, 182). Several independent attempts to replication replicate some of the 
well-known GWAS signals in the KCNJ11, CDKALI, CDKN2A/B, HHEX and BAZ1B 
loci among Indians (183-185). A recent GWAS on 12,535 Asian Indians showed that 
49/56 previously reported signals showed associations with T2DM which were similar 
to, and of the same effect sizes as, those observed in other populations; furthermore, a 
new variant in the 2q21 locus that harbors the TMEM163, RAB3GAP1 and ACMSDI 
genes was also identified and collectively all these variants explained only about 7.65% 
of variance in T2DM risk among Indians (111). Such attempts open opportunities to 
investigate the functional role of newly discovered genes in biological pathways that 
lead to T2DM and its relevant clinical significance.   
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2 THE PRESENT STUDY 
 
The effect of genetic variants on phenotypic traits is variable across populations. 
Although GWAS have helped to identify several genetic variants with disease traits, the 
results cannot be extrapolated to all ethnic groups due to differences in genetic 
background, allele frequency, patterns of LD, lifestyle and environmental factors. The 
validation of positive associations in other independent datasets, and especially those 
from high-risk ethnic groups, is crucial for identifying true population-specific variants. 
This would provide an understanding of the magnitude of genetic contribution to 
specific phenotypic traits in the population of interest. Lower birth weight, 
hyperinsulinemia, lower muscle mass, greater central adiposity and increased T2DM 
and CVD risk at any given BMI are intrinsic phenotypic characteristics of Asian 
Indians compared to the Western populations, and makes this population unique for the  
study of specific genetic effects in relation to birth weight, adiposity and T2DM.   
 
2.1 AIMS  
 
The overall aim of the current thesis is to investigate the genetic effect of GWAS- 
identified variants that associate with birth weight and adiposity in South Asian 
Indians, and also to assess whether these variants influenced glucose-insulin traits. The 
additionally aimed to study differences in body composition in Indians, compared to 
Caucasians.  
 
Specific aims:  
 
• To investigate the association of genetic variants (ADCY5 and CCNL1) with 
birth weight and diabetes-related traits in Asian Indians 
 (Paper I). 
 
• To investigate the association of common obesity variants in the FTO and 
MC4R loci to obesity-related traits in South Asian Indian adults, and 
additionally verify their effect on diabetes-related traits (Paper II). 
 
• To investigate the association of variants in FTO and MC4R to anthropometric 
measurements of adiposity and glycemic traits in Indian adolescents (Paper 
III).  
 
• To estimate the magnitude of the obesity and T2DM effect conferred by FTO 
variants in Asian Indians by meta-analysis of previously published studies 
(Paper IV).  
 
• To assess body composition differences in Asian Indians compared to 
Caucasians, using DXA. (Paper V). 
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2.2 INVESTIGATION OF GENOME WIDE SIGNALS IN ASIAN 
INDIANS 
The current thesis investigated the association of two birth weight associated genetic 
variants (ADCY5 and CCNL1), and two obesity associated variants (FTO and MC4R), 
with obesity and with diabetes-related traits in a homogenous cohort of individuals 
recruited from South India.  
 
2.1.1 Adenyl cyclase 5  
The ADCY5 gene is located on chromosome 3 (3q21.1), and encodes a member of the 
membrane-bound adenylate cyclase enzymes which mediate G protein-coupled 
receptor signaling. These enzymes are involved in the synthesis of the second 
messenger cyclic adenosine monophosphate (cAMP). The activity of adenylate 
cyclases is regulated by post-translational modification, phosphorylation state, the 
activation of other G-protein coupled receptors and by intracellular calcium signaling, 
for example through calmodulin. Two GWAS have shown robust associations for 
rs9883204 in the ADCY5 locus with birth weight (134, 136), and associations of 
ADCY5 variants with T2DM are also clear (104, 186). The association of this variant 
with birth weight has also been investigated in other populations (131, 187). However, 
the existence of any similar association has not been explored in Indians. This is of 
obvious interest, since the average birth weight is very low and the T2DM risk is high 
in this population. In the current investigation, we chose to study the rs9883204 variant 
of ADCY5, since this variant was shown to be associated with birth weight lowering to 
the extent of ~30g/allele (95% CI 23-38g) at a genome-wide significance (P= 7 x 10-15) 
(134). Also, this variant is in strong linkage disequilibrium with another SNP, 
rs11708067 (r2=0.75), which was previously shown to be associated with T2DM (188).  
 
2.2.2 Cyclin L1  
The cyclin L1 gene is located on chromosome 3 (3q25.3), and is a transcriptional 
regulator which is involved in regulation of pre-mRNA splicing. Cyclin L1 and L2 are 
members of the cyclin family (serine-rich protein family), and contain arginine and 
serine-rich domains at their C-termini. They are localized in the compartment of the 
nucleus which is rich in splicing factors (the so-called ‘nuclear speckles’), and are 
themselves involved in RNA splicing (189, 190). The Early Growth Genetics (EGG) 
consortium showed that a cluster of SNPs near the CCNL1 and LEKR1 genes were 
associated with low birth weight (~42 g; 95% CI: 35-48g) and reduced PI at birth (134). 
Ryckman et al. showed that rs900400 (CCNL1) influenced birth weight in preterm 
neonates independently of gestational age (187), and this was further confirmed in 
another independent study by Mook-Kanamori et al. (191). Although this robust birth 
weight-lowering effect was confirmed in another GWAS of Europeans and 11,848 
individuals of Asian and African origins (136), the effect of this variant in Asian 
Indians has not been studied to date. The possible underlying biological mechanisms 
are yet to be elucidated.  The current investigation included analyses of the same SNP 
of CCNL1, rs900400, owing to its robust association with birth weight, as shown in the 
previous GWAS (134).  
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2.2.3 Fat mass and obesity associated gene  
The FTO gene is a nuclear protein of the AlkB-related non-haem iron and 2-
oxoglutarate-dependent oxygenase superfamily and is located at 16q12.2 locus (192). 
FTO was first identified as one of the genes within a 1.6 megabase deletion in 
chromosome 8 and responsible for a fused toe (Ft) phenotype characterized by 
developmental defects, polydactyly, fused toes and growth retardation (193). The 
Wellcome Trust Case Control consortium discovered several SNPs within the first 
intron of FTO locus to be associated with BMI in Europeans in a GWAS for T2DM 
(82). Two GWAS that followed in succession reported three variants in intron 1 of FTO 
to be associated with early-onset childhood and adult obesity (rs1421085 and 
rs17817449), and with related traits such as body weight and WHR (rs9930506) (194, 
195). Subsequently, numerous studies using either GWAS or candidate gene 
approaches showed consistent associations with FTO variants and obesity-related traits 
in Europeans (119, 196, 197), Africans (198, 199) and Asians (200, 201). However, 
corresponding studies in an Indian population are inconsistent. The current 
investigation included an examination of the associations of rs9939609 with obesity-
related traits, since this SNP has shown the strongest effect on BMI and a 31% increase 
in obesity risk. The combined statistical power of association in the aggregate data for 
FTO and BMI is reported to be the most robust for this SNP (P = 4 x 10-51) (82). To 
date, FTO is still the locus with the largest effect size on BMI in the general population. 
FTO is widely expressed across multiple tissues, particularly in the arcuate nucleus of 
the hypothalamus, and plays a key role in energy homeostasis (202).  The mechanisms 
that underlie the FTO-obesity effect have been shown to operate through increased 
energy intake (203-205), possibly via increased dietary fat, interaction with physical 
activity (206, 207), and by reductions in satiety (208).   
 
2.2.4 Melanocortin-receptor 4 gene  
The MC4R gene belongs to the melanocortin receptor family, and is located at the 
18q22 locus. The encoded protein interacts with the adrenocorticotropic and 
melanocyte-stimulating hormone (MSH) receptors, and mediates anorexigenic 
responses to leptin in the brain (209). Endogenous antagonists include agouti and 
agouti-related protein (AgRP). Mutations in the coding region of MC4R have been 
implicated in monogenic forms of obesity (18). Recent GWAS have identified a 
common variant at ~188 kb downstream of the gene to be associated with BMI and 
obesity traits in adults and children (79). MC4R is expressed throughout the brain and 
in particularly in the hypothalamus, hippocampus and hindbrain regions (210), and 
possibly mediates an obesity phenotype through an altered balance between food intake 
and energy expenditure (209). Besides its functional role in obesity, it is shown to be 
involved in several functional pathways that regulate pigmentation, energy 
homeostasis, inflammation, immunomodulation, steroidogenesis and temperature 
control (211). Loos et al. demonstrated that a variant near the MC4R locus was 
associated with early-onset obesity, and this was convincingly replicated in 10 studies 
comprising of 60,352 adults and 5,988 children (79). Another GWAS on migrant Asian 
Indians showed an association with waist circumference (35). One cross-sectional study 
among Indian children provided evidence of an obesity association with MC4R both at 
younger ages and in adulthood (172).  A recent meta-analysis of 49 studies further 
confirmed the association of MC4R variants with obesity traits (212).  The mechanisms 
by which MC4R variants alter obesity risk are unclear, but are likely to alter MC4R 
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function or expression. In the current investigation, we genotyped the rs17782313 
variant of MC4R, which is the most convincingly replicated MC4R variant associated 
with obesity traits across different populations. 
 
2.3 SUBJECTS 
 2.3.1 The 'Vellore Birth cohort' 
The ‘Vellore Birth Cohort (VBC)’ was established in 1969-74, with a primary interest 
to study maternal health and pregnancy outcomes in geographically defined 
communities in and near Vellore, Tamil Nadu, South India (213). The study area 
included farming villages from the KV Kuppam Panchayat Union (120 miles2), 
approximately 30 kilometers from Vellore town and three districts of varying socio-
economic strata within Vellore town. The rural recruitment included 26 out of 42 
contiguous villages belonging to single region of the KV Kuppam rural development 
block. The three districts represented about one third of Vellore town population (the 
total population of Vellore town during 1969-73 is not known). According to the 2011 
population census of India, Vellore town had a total population of 3,938,106 
individuals. During the initial screening (1969-73) all married non-pregnant women of 
reproductive age were identified by house-to-house survey, and a total of 20,626 
eligible women (rural 11,628; urban 8,998) were recruited in the study (214). All 
singleton live births (n=10,670) born during the study period were included for 
longitudinal follow-up. Recruitment and follow-up are illustrated in Figure 3 below:  
 
 
Number of married women  
recruited (1969-73) 
 
 
Singleton live births 
(1969-73) 
 
 
Number of off-spring born  
in the study area 
 
 
Number of off-spring  
followed during childhood 
(1977-80) 
 
Number of children  
followed during  
adolescence (1982-88) 
 
 
Number of individuals  
followed to adulthood 
(1998-2002) 
Figure 3: Flow chart showing subject recruitment in the VBC at different time points 
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                  Figure 4: Map showing areas of recruitment for the Vellore Birth Cohort 
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2.3.2 The 'SPADES' cohort 
The SPADES cohort was established as a part of the ongoing “School Program for 
Awareness in Diabetes, Education and Screening”. The primary objective of this study 
is to implement routine screening for diabetes and promote health awareness among 
school children in Vellore town. The data for the current thesis was obtained during 
SPADES-Phase I screening, which included 11 schools and vocational training centers 
in Vellore, South India (215). The administrations of all schools, in and around Vellore 
town were contacted either by letter or telephone, to explain the objectives of SPADES 
program. All children aged over 14 years were asked for consent to participate in a 
comprehensive health check-up and biochemical testing. Out of the total 4,832 
children, 1,822 provided consent, for which complete data was available for 1,359 
subjects. Anthropometric measurements included height, weight, waist and hip 
circumference and skin fold thickness at 4 regions. Tanner’s staging was recorded as 
assessment of pubertal staging. Biochemistry included fasting and 2-hour post-prandial 
blood glucose levels and lipid profile (total cholesterol, triglyceride, high and low 
density lipoprotein cholesterol (HDL and LDL, respectively). Whole blood was used 
for DNA extraction.  
 
2.3.3The Oxford Biobank 
The Oxford biobank (OBB) includes a random sample (n=5,000) of men and women 
aged between 30-50 years, residing in Oxford, Oxfordshire, UK. The OBB was the 
first, and one of the largest, ‘recruit by genotype’ biobanks in the UK, and was 
established to study genetic, epigenetic and functional mechanisms of obesity and its 
related complications such as CVD and T2DM. Data includes detailed anthropometry 
and biochemical testing. Relevant tissue samples are stored for future studies (see 
http://www.oxfordbiobank.org.uk/) (216). 
 
2.4 Methodological considerations  
 
2.4.1 Anthropometry 
Anthropometric measurements are simple measurements of body composition. BMI 
reflects overall obesity, while measurements such as WC, HC and skin-fold thicknesses 
measure regional adiposity. These measurements are extensively used in field studies 
because of their ease of measurement and general applicability. In the current 
epidemiological investigation, anthropometry measures as listed below were used as 
proxy indicators of obesity traits. Each measurement was recorded thrice, and an 
average of three readings was used for analyses.  
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Table 2: Anthropometric measurements used in the current investigation 
 
Anthropometry Measurement Method  Unit  
Height 
  
 
Measured using a standard measuring tape and head 
positioned at Frankfurt plane  
cm 
  
 Weight 
  
Measured using a standard weighing scale to the 
nearest 0.1 kg  
kg 
 
 Body Mass Index 
(BMI) 
 
Calculated as ratio of weight (kg) and height (m) 
squared 
 
kg/m2 
 
 
 Waist 
Circumference 
(WC)  
Measured at the smallest girth between lower costal 
margin and iliac crest using a non-stretchable tape 
 
cm 
 
 
  
 Hip Circumference 
(HC) 
 
Measured at the widest circumference between the 
superior iliac crest and ischial tuberosity using a non-
stretchable tape 
cm 
 
  
 
 
 Waist-Hip ratio 
(WHR) 
Ratio of waist circumference to hip circumference 
 
 
*SFT - 
Subscapular  
 
Measured 1-2 cm diagonally from the inferior angle of 
scapula 
mm 
 
*SFT – Triceps 
 
 
 
Measured at the mid-point of the upper arm between 
the acromian process and the tip of the olecranon 
process 
mm 
 
 
   *SFT – Abdomen 
 
Measured laterally at about 2 cm from the umbilicus 
  
mm 
 
  
*SFT: Skin fold thickness measured using Harpenden Calliper (CMS Instrument, 
London)  
 
 
2.4.2 Biochemistry 
Biochemical measurements of interest in the current investigation (VBC cohort) 
included glucose and insulin, measured at serial time points (fasting, 30, 60 and 120 
minutes) following a standard 75 g oral glucose tolerance test (OGTT). Glucose was 
measured by the glucose oxidase/peroxidase method following an 8-hour fast. In paper 
III, fasting and 2-hour capillary glucose levels were measured using an Accu-Check© 
glucometer [Co-efficient of variation (CV): 1.9-2.3%]. For studies that included VBC 
samples, plasma insulin was measured by an immune-radiometric assay using Coat-a-
Count kits (Diagnostic Products Corporation, USA). Lipids were measured in fasting 
venous blood samples. Total serum cholesterol and triglycerides were measured by 
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standard enzymatic procedures, and HDL and LDL cholesterol by a direct assay 
method. The biochemical tests were performed on a Hitachi 912 auto-analyzer, using 
reagents from Roche Diagnostics (Mannheim, Germany), with the use of appropriate 
controls. The quality of these measurements was assessed using Roche Precinorm and 
Precipath controls for glucose and lipids, and BioRad Lyphocheck Immunoassay 
controls for insulin. Intra- and inter-assay coefficients of variation for insulin 
estimations were 8.0–14.5 and 8.2–13.0%, respectively. All biochemical measurements 
were done centrally at the Department of Clinical Biochemistry, Christian Medical 
College and Hospital, Vellore.  
 
2.4.2.1 Oral glucose tolerance test (OGTT) 
The OGTT is a method used to diagnose glucose intolerance and T2DM following 
administration of a standard dose (75 g) of anhydrous oral glucose, followed by serial 
measurements of plasma glucose and insulin at fasting and 30, 60 and 120 minutes. The 
OGTT mimics the normal physiological response, and reflects both β-cell insulin 
secretory capacity and the sensitivity of tissues for insulin-mediated disposal of the 
glucose load (217). IR is a common phenomenon observed in about 25% of non-
diabetic individuals, and the degree of IR is directly related to the degree of 
hyperinsulinemia (218). Several prospective studies have shown that 
hyperinsulinemia/borderline elevations in glucose levels in normal individuals are 
significant predictors of T2DM. Resistance to insulin-mediated glucose uptake is one of 
the earlier changes that can be documented before any discernible decrease in the 
insulin secretory response (219, 220). Although plasma glucose levels during an OGTT 
is determined by insulin sensitivity and insulin secretion, other factors such as incretins, 
the neural response to nutrient ingestion, gastrointestinal motility and emptying also 
influence the OGTT response. The following indices derived from OGTT were used in 
the current thesis as markers of diabetes-related traits:  
 
I. Homeostasis Model assessment (HOMA): is a model developed in 1985 which 
utilizes fasting glucose and insulin levels to predict IR and β-cell function. HOMA 
assumes a feedback loop between the liver and β-cells (221). In the normal state, the β-
cells respond to plasma glucose concentrations and produce insulin. Insulin in turn 
mediates suppression of hepatic glucose production. This loop is altered in glucose 
intolerance. HOMA%IS reflects IS and HOMA%B reflects β-cell function, but both of 
these models assume a dynamic β-cell function, which is not usually the case in states 
of impaired glucose tolerance. Therefore, a more simplified equation, HOMA-IR, is 
often used, which is a surrogate marker of IR. HOMA-IR demonstrates a linear 
correlation with glucose clamp data and minimal model estimates of IS/IR (222).  
 
II. Matsuda Index: was originally proposed by Matsuda and DeFronzo. It is an insulin 
sensitivity index that reflects estimates of hepatic and muscle insulin sensitivity 
determined from OGTT data (223). The fasting measurements reflect hepatic insulin 
sensitivity, while the mean of dynamic data reflects skeletal muscle insulin sensitivity. 
IS calculated using Matsuda Index have been shown to highly correlate with whole 
body glucose disposal rate assessed during a hyperinsulinemic euglycemic clamp (223). 
 
III. Stumvoll Index: is a measure used to predict IS and β-cell function based on 
glucose and insulin measurements obtained during an OGTT (224, 225). The original 
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equation was derived using a multiple linear regression analysis, and is based on the 
time of sample collection during OGTT and demographic parameters (BMI, age). In 
the current investigation, the modified SI based on data obtained at 0 and 120 minutes 
was used without demographic data, since the latter is not validated in the Indian 
population.  
 
IV. Insulinogenic Index: reflects the early phase insulin response, and is an index of β-
cell function (insulin secretion). The insulinogenic index is shown to correlate well with 
first phase insulin release following an intravenous glucose tolerance test (r=0.61, 
p<0.001) (226). 
 
V.AUC-glucose and Insulin: The area under the curve represents total glucose or 
insulin levels over 120 minutes recorded during an OGTT. Impaired glucose tolerance 
is reflected as a larger or increased AUC-glucose disappearance curve. Hepatic insulin 
sensitivity contributes to the shape of the glucose curve (227). 
 
 
Table 3: Measures of IS/IR derived from oral glucose tolerance test 
 
Glycemic Index Measures of Insulin Sensitivity / Insulin Resistance 
 
HOMA 
 
HOMA IR = {[Ifasting (uU/ml)] x [Gfasting (mmol/l)]} / 22.5 
 
Matsuda Index 
  
 
ISI (Matsuda) = 10,000 / √[(Gfasting(mg/dl)  x Ifasting(mU/l) x (Gmean x 
Imean)] 
 
Stumvoll Index 
 
ISI (Stumvoll) = 0.156-0.0000459 x I120 (pmol) -0.000321 x I0 
(pmol) - 0.00541 x G120 (mmol) 
Insulinogenic 
Index 
  
II = [(I30 (pmol) - I0 (pmol))/(G30 (mg) - G0 (mg)] 
 
Area under the 
curve – Glucose 
 
AUCglucose ={(30-0) x [G0 (mmol) + G30 (mmol)] + (60-30) x [(G30 
(mmol) + G60 (mmol)] + (120-60) x [G60 (mmol) + G120 (mmol)]}/2 
 
Area under the 
curve - Insulin  
AUCInsulin ={(30-0) x [I0 (mmol) + I30 (mmol)] + (60-30) x [(I30 (mmol) 
+ I60 (mmol)] + (120-60) x [I60 (mmol) + I120 (mmol)]}/2 
    
HOMA-IR: Homeostasis model assessment - Insulin Resistance; G: Glucose;  
I: Insulin; ISI: Insulin sensitivity index 
G0, G30, G60, G120: Glucose measured at 0, 30, 60 and 120 minutes following an  
oral glucose tolerance test 
I0, I30, I60, I120: Insulin measured at 0, 30, 60 and 120 minutes following an oral  
glucose tolerance test 
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2.4.3 Genotyping methods  
DNA was extracted from peripheral blood using Qiagen kits. The samples were 
genotyped using 10-20ng genomic DNA in a 384-well format on an ABI 7900HT 
machine, using a final volume of 4 µl. The genotyping was performed using the 
following TaqMan® SNP Genotyping Assays: C1860681_10 and C3035719_20 
(rs900400 near CCNL1) and rs9883204 (ADCY5), C30090620_10 (rs9939609 FTO), 
C32667060_10 (rs17782313 MC4R). The TaqMan® Genotyping Master Mix was 
used, following the manufacturer’s conditions. The genotype failure rate was 3.0% for 
rs900400, 2.8% for rs9883204, 1.5% for rs9939609 and 2.8% for rs17782313, probably 
due to low quality DNA for the platform used. In samples from the SPADES study, the 
same SNP genotyping assays were used, and the genotyping failure rate was 1.1% for 
rs9939609 and 4.6% for rs17782313. 
 
2.4.4 Body composition estimation using DXA 
In Paper V, the body composition of migrant Asian Indians and matched controls from 
the OBB was estimated using DXA (GE Health Care Lunar iDexa, with software 
version 14.1). The algorithm used by the iDXA software performs quantification of 
VAT and trunk/android fat mass with high accuracy (64).  
 
2.4.5 Statistical methods 
In all studies, baseline characteristics were summarized using descriptive statistics. 
Data for all normally distributed variables are presented as mean and standard deviation 
(SD). For skewed variables, the data were either presented as median and inter-quartile 
range (IQR), or log transformed and presented as mean and SD.  
 
In paper I, the association between the genotypes and phenotypic traits were tested 
using analysis of variance (ANOVA) for normally distributed traits, and the Kruskall-
Wallis test for skewed variables. Adjustments for covariates were performed only in 
ANOVA models. In Papers II and III, linear regression analysis was performed to 
compute the effect size for the additive models, using quantitative traits as the 
dependent variable and genotypes as the independent variables. Possible confounding 
factors (as appropriate for the study) were adjusted. An additive genetic model was 
considered in all the genetic studies based on the assumption that the overall genetic 
variation contributing to the phenotype variability is due to the sum of individual 
effects of multiple loci (genotypes) (228) and that there is no interaction between the 
alleles within a locus or between loci (228). The genotypes of all SNPs were analyzed 
for deviation from Hardy-Weinberg equilibrium using χ2- analyses (229). We did not 
adjust for multiple comparisons, as the variants were chosen based on strong prior 
hypotheses, and all genetic variants tested were well-established lead signals in 
previous GWAS.  
 
2.4.5.1 Meta-analysis 
Meta-analysis (MA) is a method of combining results from different studies. MA is 
usually performed either on extracted data from published studies or individual data 
sets. Results may be combined with an inverse-variance weighted fixed effect model or 
a random effect model. In the fixed effect model, it is assumed that only one true effect 
size underlies all studies, and the differences in observed effects are due to sampling 
errors, while in the random effect model the true effect could actually vary between 
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studies (230). The results of the meta-analysis are usually represented graphically with 
forest-plots, in which the study-specific results are shown together with the estimated 
combined effect. Unfortunately, smaller studies or studies with negative results are 
often unpublished, and this might affect the study estimates of a meta-analysis. Funnel 
plots are a way of assessment of publication bias in a meta-analysis, and plots the 
measure of study size on the vertical axis and function of effect size on the horizontal 
axis (231). Two tests are commonly employed to quantify the amount of publication 
bias captured by the funnel plot, namely the Beggs and Mazumdar’s rank correlation 
test, and Egger’s regression test. The trim-and-fill method is a nonparametric method 
used to estimate the effect of the missing studies on the final outcome (232). Meta-
analysis of genetic association studies has gained considerable importance, especially 
when independent candidate genetic studies have shown inconsistent results, obviously 
as a result of their lower statistical power (233). Heterogeneity tests are generally 
performed to determine if there are genuine differences in the cumulative results or 
whether variation in the findings is a chance occurrence (234, 235). This is usually 
tested using a Cochran’s Q-test. This is quantified using I2 statistics, which describes 
the total variation (degree of inconsistency) across the studies that is due to 
heterogeneity rather than by chance. Heterogeneity is considered low, moderate or 
high, based on I2 values of 25%, 50% and >75%, respectively (234). Meta-regression  
was performed to identify sources of heterogeneity and examine moderators of overall 
association. In Paper IV, extracted data from original publications were used for meta-
analysis. We performed random effects model and the results are presented as forest 
plots with corresponding estimates as either β or odds ratio (OR) along with 95% CI as 
applicable. Appropriate tests for heterogeneity and publication bias were included to 
validate the conclusions.  
 
2.5 RESULTS 
 
2.5.1 Paper I - ADCY5 and CCNL1 study 
The association between the common variants rs9883204 (ADCY5) and rs900400 (near 
CCNL1) with birth weight and adult diabetes-related traits was investigated in 2,151 
South Asian Indians. Despite the relatively low mean birth weight of the cohort (mean 
± SD: 2.7 ± 0.5 kg), genetic variants in ADCY5 and near CCNL1 did not demonstrate a 
birth weight -lowering effect in this population. The MAFs of the risk alleles were 
comparable to that of the original population included in the GWAS by Freathy et al. 
(MAF rs900400: Indians 21%, Europeans in GWAS 32-47%; MAF rs9883204: Indians 
81%, Europeans in GWAS 71-83%), and no gene-dose effect with respect to birth 
weight was observed. In line with the previous GWAS publication by Freathy et al. in 
which variants near the CCNL1 locus demonstrated an association with reduced 
ponderal index (PI) at birth (p=5 x 10-21), we re-analyzed the data and found an 
association with reduced PI at birth for both rs900400 and rs9883204 genotypes 
(p=0.0009 and p=0.005 respectively, Table 4), but no significant association with birth 
length or head circumference. Examination of the relationship with diabetes-related 
traits showed rs9883204 to be associated with increased fasting and 120 minute glucose 
values, and with reductions in the insulinogenic index and 120 minute insulin levels, all 
of which argue for a common genetic link between birth weight lowering variants and 
risk of T2DM (236). The near CCNL1 variant did not show any association with 
T2DM-related traits, consistent with the Freathy et al. report (134). 
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Table 4: Association of rs900400 (CCNL1) and rs9883204 (near CCNL1) with 
Ponderal index  
 
 0 1 2  P value  
rs900400 
Birth weight (kg) 2.79 (0.47)  2.80 (0.45) 2.80 (0.53) 0.87 
Birth length (cm) 48.1 (2.7) 48.0 (2.7) 47.9 (2.5) 0.53 
Ponderal Index 25.2 (4.3) 25.8 (4.6) 24.2 (3.9) 0.0009 
Adult weight 53.2 (11.58)  53.3 (11.60) 55.5 (12.18) 0.13 
Adult height  160.4 (9.0) 160.0 (8.8) 162.2 (5.3) 0.059 
Adult BMI 20.6 (3.79)  20.8 (3.81) 21.0 (3.94) 0.42 
rs9883204 
Birth weight (kg) 2.78 (0.46) 2.80 (0.46) 2.77 (0.55)  0.54 
Birth length (cm) 49.1 (3.0) 48.5 (2.8) 47.8 (2.6) <0.00001 
Ponderal Index 25.4 (4.2) 25.4 (4.6) 23.8 (4.7) 0.005 
Adult weight 53.5 (11.65) 53.2 (11.44) 52.4 (11.97)  0.80 
Adult height  160.2 (8.8) 160.1 (9.0) 160.5 (9.3) 0.90 
Adult BMI 20.7 (3.76) 20.7 (3.80) 20.3 (4.16)  0.64 
rs900400 represents near CCNL1 variant and rs9883204 represent ADCY5 variant. 0, 
1, 2 represent number of risk alleles. Ponderal index calculated as ratio of weight (kg) 
divided by height (m) cubed.  
 
2.5.2 Paper II – FTO and MC4R in adults study 
An examination of the obesity- and diabetes-related effects of the rs9939609 (FTO) and 
rs17782313 (MC4R) variants in a cohort of 2,151 (males: 1,118 and females: 1,034) 
individuals (mean ± SD age: 28.3 ± 1.1 years) from South India showed that rs9939609 
(FTO) is associated with obesity-related anthropometric traits in adulthood, and that 
this effect appeared to be greater in the urban setting. Similar effects were not observed 
in younger age groups. The relatively stronger association between rs9939609 and skin 
fold thickness measurements which reflect SAT is reported for the first time in Asian 
Indians. Obesity associations with the MC4R variant was significant for total weight 
and regional adiposity measurements (WC and HC), but these were abolished when 
adjusted for height demonstrating that these associations are driven by body frame. The 
study was  adequate powered at 86% to detect the 0.4% variance explained by MC4R 
previously (237). Analysis of longitudinal data, showed a significant association for 
rs9939609 with adult Z-scores of weight (p=0.024) and BMI (p=0.006), and 
rs17782313 with adult and adolescent height (p=0.047 and p=0.002 respectively). The 
association with height observed with rs17782313, is consistent with the previous 
observations in other populations, and suggests that polymorphisms in the MC4R locus 
relate to accelerated linear growth  
  
 
2.5.3 Paper III – FTO and MC4R in adolescents study 
Detailed investigations of the association between regional adiposity measurements and 
obesity-related genetic variants in younger age groups were not possible in Paper II, 
due to the limited availability of specific anthropometric measurements that reflect 
body fat distribution. The focus of the former study therefore was limited to only 
associations with overall obesity (Z-scores of BMI) in younger age groups. In Paper 
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III, the independent effects of these variants with respect to specific adiposity 
measurements were investigated in a cohort of 1,226 adolescents (mean ± SD Age: 
17.1 ± 1.9 years) from South India (the SPADES cohort) (238). The results showed a 
significant association between rs9939609 (FTO) and WHR in adolescents, and this 
was significant even after adjusting for BMI and height. FTO demonstrated an 
increased abdominal obesity risk, based on the 95th percentile cut-off of WHR (OR 
1.46; 95%CI 1.03-2.04, p =0.031). Although this association may point towards an 
effect on fat redistribution, it is unlikely considering, firstly, that FTO has not 
demonstrated any similar association in large datasets or GWAS, and secondly, that 
genetic loci that regulate body fat distribution are distinct from those that associate with 
obesity and BMI. Nevertheless, this finding could be important because the 
independent association of WHR with increased cardio-metabolic risk is well 
documented among Indians (59, 145). The study was not sufficiently powered to detect 
associations between with MC4R variant and obesity-related traits in this population.  
 
2.5.4 Paper IV – Meta-analysis of FTO variants study 
There is a considerable discrepancy in the literature about the association of FTO 
variants with obesity-related traits in Asian Indians. Therefore, in Paper IV, a meta-
analysis of all published literature on FTO and diabetes and/or obesity traits in Asian 
Indians (both migrant and indigenous) was performed to confirm/refute the association 
of FTO variants with obesity traits and T2DM in Indians. Pooled data from eight 
studies (n=28,394) showed an increased risk with obesity (OR 1.15, 95% CI 1.08 -1.21, 
p=2.14 x 10-5) and related traits such as BMI (β=0.30 kg/m2, 95% CI 0.21- 0.38, p = 
4.78 x   10-11), WC (β=0.74 cm, 95% CI 0.49-0.99), HC (β=0.52, 95% CI 0.26-0.78) 
and WHR (β=0.002, 95% CI 0.001-0.004). The results of our meta-analysis also 
showed an increased risk for T2DM (OR 1.11; 95%CI 1.04-1.19, p=0.002), which 
attenuated when adjusted for age, gender and BMI (OR 1.09; 95% CI 1.02-1.16, 
p=0.01). This points towards a FTO-diabetes-effect that is partially mediated through 
BMI, contrary to the early literature that showed the effect of FTO on T2DM to be 
independent of BMI in Asians (176, 178). The estimates of FTO effects on obesity 
related traits and T2DM are summarized in Table 5. Heterogeneity was observed for 
T2DM and WC, and meta-regression did not identify any potential confounders. There 
was no evidence of publication bias observed for obesity-related traits. Publication bias 
as assessed by funnel asymmetry was observed for T2DM. The adjusted estimate as 
analyzed using trim and fill technique re-estimated overall diabetes risk after 
imputation of the missing studies and was not significant (OR 1.07: 95%CI 0.97-1.18, 
p=0.162).  
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Table 5: Summary of overall estimates of FTO on obesity-related traits in Asian 
Indians  
 
† Type 2 diabetes risk adjusted for age and gender ‡Type 2 diabetes risk adjusted for 
age, gender and BMI. *Estimates represented as odds ratios (OR). 
 
 
2.5.5 Paper V – Body composition in Asian Indians study 
Ethnic differences in body composition are an important determinant of cardio-
metabolic risk especially in Indians. The approach described in Paper V was designed 
to test whether any differences exist in VAT in migrant Asian Indians, compared to 
Caucasians. Using iDXA, detailed body composition characteristics were compared 
between 26 migrant Asian Indians in Oxford, UK and 78 Caucasians from the Oxford 
Biobank (OBB), matched for age, gender, BMI and height. As expected, at any given 
BMI, the total body fat percentage as estimated by iDXA was higher in Asian Indians, 
compared to Caucasians.  For example, as shown in the Figure5, at a BMI of 22, the 
body fat percentage of Indians is ~30%, while in Caucasians this is much lower 
(corresponding to ~20%). However, at higher BMI, the difference between the 
ethnicities appears to be steeper i.e. at a BMI of 30 kg/m2, the body fat percentage in 
Indians and Caucasian corresponds to approximately 36% and 30%, respectively. 
Despite a lower lean mass (-11%, p=0.0001) and higher total fat mass (+25%, 
p=0.0008), no difference in VAT was observed was observed. Similarly the 
visceral/android ratio, which describes the proportion of fat that is inside the body 
cavity within the DXA defined ‘Android’ area, did not show any significant difference 
between both ethnicities and genders (42% in Asian Indians 125 and 55% in 
Caucasians). With increasing adiposity, Asian Indians demonstrated a more 
homogenous distribution of body fat which was largely subcutaneous. The association 
between total body fat and leg fat was linear, pointing towards a more homogenous 
distribution of excessive body fat (mainly in the form of SAT) similar to that observed 
in Caucasians.   
 
Phenotypic traits  n β / OR (95% CI) P value  
Body mass index (kg/m2) 28,394 0.30 (0.21, 0.38) 4.78 x 10-11 
Waist circumference (cm) 28,394 0.74 (0.49, 1.00) 0.001 
Hip circumference (cm) 28,394 0.52 (0.26, 0.78) 0.0009 
Waist-hip ratio  28,394 0.002 (0.0001,0.004) 0.001 
*Obesity risk  24,987 1.15 (1.08, 1.21) 2.14 x 10-05 
*Type 2 diabetes risk† 24,987 1.11 (1.04, 1.19) 0.002 
*Type 2 diabetes risk‡  24,987 1.09 (1.02, 1.16) 0.013 
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Figure 5: Correlation between body mass index (BMI) and DXA measured body fat 
percentage in Indians and Caucasians.  
 
                                                   Caucasians;        Indians  
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3 DISCUSSION 
The current thesis investigated the genetic contribution to birth weight, obesity and 
diabetes-related traits in Asian Indians. This was addressed by examining the genetic 
effects of well validated gene-disease associations in large homogenous cohorts of 
Asian Indians. The current investigation is an attempt to verify the extent to which 
common variants of genome-wide significance in Caucasians have similar effects in 
Asian Indians.  
 
Birth weight is a robust indicator of neonatal well-being, and there are well-
documented epidemiological observations that show an inverse correlation between 
birth weight and adult cardio-metabolic risk. Evidence of genetic regulation of birth 
weight independent of intra-uterine environment, is illustrated by correlations between 
paternal height or weight and offspring birth weight (239, 240). The common genetic 
link between birth weight and increased risk for adult T2DM additionally accounts for 
some of the observed correlation between these phenotypes (128, 132).  In the current 
investigation, the absence of any birth weight-lowering effect observed for both 
ADCY5 and near CCNL1 variants is most likely due to the lower statistical power of the 
study (power: 74% for variant near CCNL1, and 32% for the ADCY5 variant). Other 
possible reasons could be related to non-genetic factors (intra-uterine environment, 
maternal nutrition) that predominate over any genetic effects in Asian Indians. 
Although an association with birth weight was not observed, we extended our 
investigation to see if these variants had any effect on skeletal growth or fat mass at 
birth. We observed an association with reduced PI for both ADCY5 and CCNL1 
variants consistent with the original GWAS observations by Freathy et al. where 
CCNL1 was related to PI (134). In the absence of a birth weight lowering effect, we 
believe that this association must be spurious. PI is a  measure of leanness at birth, and 
studies have shown that it reflects nutritional status of a new born independently of 
gestational age (241). However, by definition, PI appears to be the same as BMI, and 
both measurements provide information on weight controlled for height. Length at birth 
being is a specific measurement representing skeletal growth, and weight is a 
composite measure of the newborns fat, lean, bone and visceral mass. A significant 
association with a derived measure such as PI fails to provide any meaningful 
explanation regarding the genetic regulation of fetal growth in Indians and appears to 
neither reflect ‘leanness’ nor ‘adiposity’ at birth. The genetic association of PI with 
near CCNL1 variants has been inconsistent in other studies (191, 242). A recent GWAS 
demonstrated an association between variants in the genomic region of 3q25 (LEKRI 
and near CCNL1 genes) and skin fold thicknesses measured at birth, suggesting that the 
birth weight -lowering effect of these variants is secondary to an effect on subcutaneous 
fat (243). Data on SFT at birth is not available in the VBC, and it would be interesting 
to test this relationship among Asian Indians, who preserve greater subcutaneous fat 
even at birth (126, 244).  
 
The association with higher fasting and 120 minute glucose levels suggests a possible 
role for ADCY5 in the regulation of hepatic glucose production and/or insulin secretion, 
and the association with reduced insulinogenic index additionally points towards a role 
in insulin secretion. In a well-powered study among Indians, if an association is 
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demonstrable for both birth weight and adult glycemic traits, then the mechanism 
explaining such an association might be due to a direct effect of the fetal risk allele on 
fetal growth via reduced insulin secretion, consistent with fetal insulin hypothesis. The 
current study has few limitations and needs emphasis beside limited statistical power. 
The SNPs genotyped in the current study do not represent the causal variant, implying a 
need for the identification of other variants that could explain low birth weight in 
Indians. We acknowledge that our study was limited to examining the strongest GWAS 
signals only, and other possible candidates such as CDKAL1 and HHEX-IDE, which 
showed large effect sizes in meta-analysis (132), were not chosen since the independent 
effect of these variants on birth weight is relatively small.  
 
To date, the most robust and consistently replicated genetic variants of obesity are 
SNPs within the FTO and MC4R locus.  FTO variants increased obesity risk by 1.20-
1.30 fold in Europeans, and the risk allele was associated with a 0.39 kg/m2 (~1000 
g/allele) increase in BMI (75, 78). MC4R variants were associated with BMI increases 
of 0.23 kg/m2 (~600 g/allele) in Caucasians. However, replication of these associations 
in Indians has been variable. In Paper II, per allele (rs9939609) increases of ~1% for 
BMI, WC, HC and WHR and skin-fold thickness (SFT) during adulthood are similar to 
effect estimates reported in the Caucasian population. The association of rs9939609 
with more specific measures of SAT suggests that SFT measurements probably reflect 
adiposity better than other conventional anthropometric measurements in the thin-fat 
Indian phenotype. This is important, because previous studies have shown that SAT, as 
measured by subscapular skin folds, is well preserved even at birth (126, 245) and 
persists through adulthood in Indians (245, 246).  The relatively stronger associations 
with regional adiposity traits compared to overall obesity, allows us to reconsider the 
definition of obesity in Indians since traditional BMI or WC cut-offs may only be 
applicable within populations, but not when inter-ethnic comparisons are made. We 
observed a relatively more stronger FTO-obesity effect in the urban than rural setting 
which suggests that the impact of these genetic effects are more pronounced in 
individuals who are genetically susceptible when they are exposed to an obesogenic 
environment such as urban living. This also partially explains the increasing prevalence 
of obesity and overweight in urban Indian cities, compared to rural India. Our study 
could not demonstrate FTO effects at younger age groups, probably due to two reasons 
ii) limited sample size in younger populations ii) that the effect of FTO genotypes on 
obesity is stronger during adulthood among Indians, while these effects may be weak 
and undetectable in younger age groups, unlike other ethnic groups where FTO effect 
was observed both during childhood and in adults.  
 
The association of genetic variants in the FTO and MC4R loci in younger age groups is 
evident both from GWAS (79, 82, 247) and longitudinal studies (248-250). Hardy et al. 
demonstrated an age-dependent effect of these variants, with stronger effects observed 
during childhood and adolescence and weaker effects during adulthood (248). A recent 
meta-analysis of 13,071 children and adolescents identified 15 genetic variants, 
including FTO and MC4R, which were associated with obesity-related traits (251). The 
results from our study showed an effect of FTO on WHR. The FTO effect on overall 
obesity does not emerge in our study, possibly because the individuals in this cohort 
were relatively leaner (mean BMI 20.4 ± 4.0). The increased risk for central adiposity 
(independent of height and BMI) conferred by rs9939609 signifies that body fat 
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distribution is independent of overall obesity, and in populations such as Asian Indians, 
who are vulnerable to central adiposity, WHR may be an important measurement of 
adiposity particularly in younger age groups with normal BMI. However, this 
association needs to be viewed with caution, since FTO did not significantly emerge at 
the genome-wide level for body fat distribution in European ancestry (251), and 
because overall obesity regulating-variants are distinct from variants that modulate fat 
distribution. We also acknowledge that the FTO-WHR relationship was modest, and 
did not hold for Bonferroni correction, and therefore larger datasets are required to 
reconfirm a strong statistical association of FTO with regional measurements of 
adiposity in younger Indians. It is important to note that a significant association with 
one of the traits, and a non-significant association with another, does not necessarily 
preclude the overall obesity effects of FTO, and points towards a complex interplay 
between genes and environment in obesity regulation at different ages. This study was 
also limited by statistical power to test for a gender-specific relationship for the FTO-
WHR association.   
 
The lack of demonstrable associations with the MC4R variant and obesity-related traits 
in the current investigation may be due to insufficient statistical power. The earliest 
GWAS which demonstrated an association of a locus near MC4R required a much 
larger sample size, firstly because the risk allele frequency is lower, and secondly 
because the effect size is smaller than that observed for the FTO locus (79). The allele 
frequency of MC4R variants in Asians is relatively higher, compared to that in other 
ethnic groups (~40% in Asians vs. ~27% in Europeans) (35, 171, 237), yet much larger 
samples appear to be required to estimate the true effect of MC4R on obesity-related 
traits. It is also possible that the ethnic-specific association of rs17782313 with obesity-
related traits could be weak in Asian Indians, and the existence of a causal SNP with a 
much stronger effect needs further investigation. Investigations concerning the 
association of MC4R variants with obesity traits have been reported among Indians, but 
both reports have been confounded by the inclusion of cases with T2DM with higher 
BMIs (171, 172). Contrary to our findings in younger age groups, a recent report 
among 1362 children (mean age  ± SD: 20.6 ± 5.1 years) from North India has shown a 
strong association of two SNPs in the MC4R locus with adiposity related traits (172).  
 
The combined meta-analysis of 28,394 Asian Indians further confirmed that FTO-
obesity risk in similar in both Indians and Caucasians, with an approximate 1% 
increment in all adiposity traits. Previous independent  investigations of the effects of 
FTO in Asian Indians were largely confounded by factors such as the i) inclusion of 
T2DM cases, a large majority of whom exhibited increased BMI ii) population 
heterogeneity due to the admixture of Indians from different geographical regions and 
cultural backgrounds, iii) by lower statistical power (174, 176-178, 252). The meta-
analysis has addressed some of these issues by improving statistical power and testing 
for heterogeneity across studies using appropriate statistical methods and by the use of 
meta-regression to identify potential confounders. Therefore, the results of this meta-
analysis are robust and confirm the FTO-obesity risk in Indians. Examination of the 
FTO-T2DM association additionally suggests that the association between FTO and 
T2DM is partially mediated through the genetic effects on BMI contrary to the earlier 
belief among Asian Indians that FTO is a T2DM risk loci. One important caveat in our 
study was that we were unable to evaluate the effect of regional adiposity on T2DM, 
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since the meta-analysis was performed on data extracted from literature, and a 
combined analysis of independent data sets would have provided the opportunity to 
investigate an association of T2DM with regional adiposity in Asian Indians. This 
would be important in a centrally obese Indian population. We acknowledge our study 
overlapped with samples included in the recent meta-analysis of ~ 97,000 Asians by Li 
et al. However, we did not find any major inconsistencies between our results based 
solely on Indians for FTO effect, which strengthens the validity of the overall estimates 
obtained in the current study. Also we consider that the results of the meta-analysis by 
Li et al. cannot be generalized to all Asian populations because phenotypic differences, 
genetic heterogeneity and population specific environmental influences are reported 
extensively even within the Asian subgroups, and these differences are likely to 
account for the heterogeneity observed in the Asian study (179).  
 
Further to the validation of genetic associations and the relatively stronger association 
of FTO variants with SFT that reflects subcutaneous adiposity, the current investigation 
was extended to clinically evaluate differences in regional abdominal adiposity depots 
in migrant Asian Indians, compared to Caucasians. The results of this study establish 
two important findings in relation to body composition in Indians: i) against 
expectation, and despite the presence of considerably higher overall body fat content in 
Indians, no meaningful differences in VAT content in Asian Indians is observed, 
compared with Caucasians. ii) the lower muscle mass, as reported by us, is consistent 
with several previous reports in Asian Indians, and further confirms that sarcopenic 
obesity is a characteristic feature of Asian Indians.  
 
In the absence of excessive VAT, fat tissue may be distributed more homogenously in 
Indians, probably in the form of larger SAT depots, allowing the speculation  that 
excessive SAT in the presence of lower lean mass (specifically, skeletal muscle) could 
possibly be a detrimental determinant of increased cardio-metabolic risk. Only a few 
reports among indigenous (167, 253) and migrant Indian populations (1, 62, 147) have 
highlighted the relationship of SAT with cardio-metabolic risk. The characteristics of 
the seemingly expanded SAT depot seen with obesity in Indians need more detailed 
investigation in larger datasets. It allows speculating that adiposity per se cannot fully 
account for the increased chronic disease risk, and the existence of a factor beyond 
adiposity needs identification.  
 
The accumulation of active lipid intermediates such as long chain fatty acyl-CoA, 
diacylglycerol and ceramides in the skeletal muscle is shown to play a causal role in IR 
(254). Forouhi et al. showed excessive intra-muscular triglycerides (IMTG) (~30%) in 
Asian Indians compared to Caucasians, pointing towards increased cytosolic lipid 
accumulation and defective lipid metabolism in skeletal muscle (170). Muscle mass is 
known to inversely relate to IS and correlates significantly with reduced glucose 
disposal in Indians (255). Hall et al. in a series of experiments on skeletal muscle 
function and its role in IR among south Asians compared to Caucasians, showed that 
Asians oxidized less fat (~40%) during submaximal exercise,  had reduced skeletal 
muscle expression of key insulin signaling proteins (IRS-1), and that V02max and fat 
oxidation correlated significantly with whole-body IS (256). They additionally report 
that the IR phenotype cannot be explained by reduced skeletal muscle expression of 
genes involved in oxidative and lipid metabolism, since individuals with the highest 
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expression of these genes oxidized the least fat during exercise. Nair et al. reported that 
mitochondrial dysfunction does not account for the IR phenotype in Asian Indians, 
despite higher skeletal muscle capacity for oxidative phosphorylation, and higher 
mtDNA content was seen in muscle biopsies.  Collectively these studies suggest that 
the reduced capacity to oxidize fat during submaximal exercise is a more important 
determinant of IR phenotype in Asian Indians, rather than mitochondrial capacity to 
oxidize lipids (257). We speculate that lower muscle mass is probably unable to 
compensate for the higher lipid content in the muscle and therefore exhibits a reduced 
capacity to oxidize fat. This warrants future investigation concerning the role of skeletal 
muscle mass in the presence of higher fat mass in the pathogenesis of T2DM in Asian 
Indians.  
 
 
4 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
The results of this thesis provide important conclusions on T2DM risk determinants in 
Asian Indians: i) the association between ADCY5 variant and adult glycemic traits 
reinforces that that fetal-insulin hypothesis could be an important mechanism that 
underlies T2DM etiology in Indians ii) obesity determining genetic variants  
demonstrate a relatively stronger effect on regional adiposity and proxies of SAT than 
overall obesity which underscores that SAT may have an important role in obesity-
related complications in Indians  iii) the absence of differences in VAT, and the 
relatively higher subcutaneous adiposity along with  lower lean mass (particularly 
skeletal muscle), are intrinsic features of Indians and the exact role in the pathogenesis 
of IR/T2DM needs detailed investigation.  
 
Genetic association studies amongst Indians have largely been replication attempts of 
genome-wide significant signals that emerged from GWAS in populations of European 
ancestry. Recent efforts to integrate independent cohorts into larger consortia by the 
Indian Genomic Variation initiative (157, 158), hopes to facilitate validation of genetic 
markers in a large scale and also allow discovery of new genetic variants with use of 
high throughput genomic methods including the ‘omics’ platforms. This approach 
would provide important biological insights into the pathogenesis of complex disease in 
this Asian Indians.   
 
In a broader perspective, conventional genetics in general appears to explain very little 
of the phenotypic variation in complex disease phenotypes, and variants, individually 
or in combination, confer relatively small increments in disease risk (1.1-1.5 fold) 
(258). This stimulates exploration of proposed variants that could explain the ‘missing 
heritability’, including variants of low MAF (0.5% to <5%), rare variants (MAF 
<0.5%) and structural variations such as CNV, insertions and deletions (259). Other 
areas that remain equally important are investigations of potential environmental 
confounders, gene-gene interactions, gene-environmental interactions, and their 
biological implications in complex disease pathology, especially in understanding 
obesity phenotypes where gene x environment interactions have shown to play an 
important role (260).  
 
 34 
More specifically, the results from Paper I make the fetal origins hypothesis an 
attractive area of research in Indian populations, considering that distinct IR and 
adiposity-related phenotypic characteristics are exhibited at birth in this population. 
These observations warrant further studies that investigate common genetic variants 
that associate with both phenotypes among Indians. Identification of causal variants 
appears to be important in all genetic studies. An example for this is that the birth 
weight signal marked by rs900400 maps approximately 353 kb 3-prime to the leucine, 
glutamate and lysine rich 1 (LEKR1) locus, and 67 kb 3-prime to CCNL1. Neither of 
these genes has been implicated in previous GWAS, and their functions appear to be 
unknown. Therefore other approaches, such as resequencing and functional studies, 
will be required to establish which gene (CCNL1, LEKR1 or another gene) actually 
mediates the effect on birth weight. Also, epigenetic processes are strong candidates for 
mediating the above traits. This is demonstrated in animal models, in which a causal 
link between early nutritional status and epigenetic changes predisposing to adult 
T2DM and obesity risk have been demonstrated (261). Therefore, investigations of the 
molecular basis of fetal programming that involves DNA methylation may provide 
substantial new knowledge on mechanisms that link fetal growth and adult disease. 
Epigenetic mechanisms may also underlie the propagation of obesity from mother to 
child by a ‘thrifty epigenotype’ mechanism, and this opens opportunities for genome-
wide assessment of epigenetic variation (262). An understanding of genetic and 
epigenetic associations will therefore illuminate the biological pathways important for 
fetal growth and its relationship to adult disease. 
 
With regards to the genetic effects of FTO and MC4R, the biological mechanisms 
responsible for the association with obesity-related traits remain elusive. Given that 
these loci are highly expressed in the hypothalamus (192), and that evidence for their 
association with appetite regulation, energy intake and satiety has been provided from 
human studies (263, 264), it is expected that their obesity effects may be related to 
dysregulation of satiety leading to overfeeding. Studies have also shown that the effect 
of these variants on common obesity is attenuated with alteration in life-style, 
particularly physical activity (263, 265). So far, this remains unexplored in Indians, and 
warrants well-designed clinical trials to infer a causal relationship. Epigenetic 
mechanisms that underlie common obesity are still largely unknown, and there is 
emerging evidence that supports the role of both genetic and environmental interactions 
with epigenetics to perpetuate disease risk which requires further exploration (266).  
 
The facts that the genetic variants tested here associate relatively strongly with SAT 
measures, and that DXA did not show any difference in VAT, warrant more detailed 
epidemiological and clinical studies investigating the role of specific adipose depots 
and skeletal muscle and its relationship cardio-metabolic disease. This would be  
particularly insightful in this population since most studies have highlighted the 
importance of VAT in Indians and very few recent evidence provide support for the 
role of SAT in disease risk. More functional knowledge relating to individual pathways 
or genes can be gained by in vitro studies on biopsy specimens obtained from different 
adipose depots and skeletal muscle.  
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5 SAMMANFATTNING PÅ SVENSKA 
 
Genetiska faktorer spelar en väsentlig roll för känsligheten för vanliga kroniska 
sjukdomar såsom diabetes or hjärt och kärlsjukdomar (multifaktoriella eller komplexa 
sjukdomar). Framsteg inom identifieringen av genetiska varianter, gjorda via 
genotypning i stor skala, har hjälpt till att fastställa flera genetiska varianter som ger 
ökad risk för komplexa sjukdomar. Denna avhandling utfördes för att undersöka 
effekten av genetiska varianter associerade med låg födelsevikt och fetma hos  indier 
och bedöma om dess genetiska markörer har en effekt liknande den hos europeer. 
Avhandlingen syftar också till att belysa skillnader i kroppssammansättning mellan de 
två populationerna, särskilt bukfetma som en trolig bidragande orsak till för tidig hjärt 
och kärlsjukdom hos indier. 
 
För studien användes data från "Vellore birth Cohort ", vilket är en longitudinell 
födelsekohort som startades 1969-1973 i närheten av Vellore, Tamil Nadu, i södra 
Indien. Alla överlevande ensamfödda (n = 10,670) som nedkom under studieperioden 
inkluderades i den longitudinella uppföljningen och de undersöktes vid olika tidpunkter 
(födelse, barndom, tonår och vuxenliv). För de genetiska studierna, inkluderades de 
2,218 personer som fullföljde alla fyra tidpunkterna. Några väletablerade genetiska 
varianterna för födelsevikt (ADCY5 och nära CCNL1) och fetma (FTO och MC4R) 
testades för relevanta associationer med tillgängliga variabler såsom födelsevikt, 
glukos- och insulinrelaterade variabler respektive överviktsparametrar  hos vuxna. 
Vidare studerades effekten av FTO och MC4R i en annan kohort bestående av 1,200 
ungdomar i 17-års åldern. Resultat från dessa studier samt oklarheter i den tillgängliga 
litteraturen ledde också till en studie i syfte att gen en detaljerad kartläggnng av 
fettvävsfördelning hos indier i jämförelse med europeer.  
 
Födelseviktsstudien visade inget samband mellan födelsevikt och de två genetiska 
varianterna för födelsevikt hos i den indiska populationener. En möjlig förklaring kan 
vara att det finns icke-genetiska faktorer (intrauterin miljö, moderns nutritionsstatus 
etc.) som dominerar över de genetiska effekterna. Däremot fann vi att den genetiska 
varianten ADCY5 var associerad till förhöjda glukos- och minskade insulinnivåer hos 
unga vuxna, vilket talar för en generell genetisk koppling mellan födelsevikt och risk 
för typ 2 diabetes. I studien  där sambandet mellan genetiska fetma varianter och fetma 
variabler undersöktes fann vi ett samband mellan FTO varianter och både generell och 
regional övervikt hos vuxna, till skillnad från de yngre åldersgrupperna, där sambandet 
var starkare för regional fetma. Vi bekräftade detta samband i en meta-analys på 23,982 
indier.  
 
En stark association mellan FTO varianter och underhudsfett gav inspiration till en mer 
detaljerad analys av fettvävsfördelninghos indier och europeer. Det fanns ingen skillnad 
i visceral fetma, men indier hade lägre muskelmassa och ökat generellt subkutant 
kroppsfett. Denna studie visade att det finns principiella skillnader is fettvävsfördelning 
och kroppsammansättning mellan indier och europeer..  
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Resultaten från denna avhandling visar att genetiska varianter som predisponerar för 
övervikt har ungefär samma effekt hos indier som hos europeer. Avsaknaden av 
genetisk påverkan på födelsevikt hos indier skulle kunna förklaras av icke- eller 
epigenetiska faktorer. Trots detta indikerar sambandet med insulin nivåer hos vuxna att 
gener som reglerar födelsevikten samspelar med uppkomsten av vuxendiabetes. 
Avsaknaden av skillnader i visceral fetma mellan de två etniska grupperna leder till 
slutsatsen att fettinlagringen hos indier framför allt sker subkutant. Ytterligare studier 
krävs för att undersöka om subkutant fett är skadligt och innebär större risk för hjärt-
metabol, kärl och diabetessjukom hos indier. 
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